ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.3%
5Y CAGR+4.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.3%/yr
vs +12.7%/yr prior
5Y CAGR
+4.4%/yr
Consistent
Acceleration
-6.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $877.70M | +36.0% |
| 2024 | $645.16M | -14.4% |
| 2023 | $754.09M | +3.2% |
| 2022 | $730.66M | +15.0% |
| 2021 | $635.44M | -10.2% |
| 2020 | $707.79M | +25.0% |
| 2019 | $566.02M | +25.0% |
| 2018 | $452.92M | +12.0% |
| 2017 | $404.25M | +41.5% |
| 2016 | $285.74M | - |